
Arlckon Biotech Private Limited
About Arlckon Biotech Private Limited
Data last updated:
Arlckon Biotech Private Limited is a private limited company based in Ambernath, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2021PTC355143. Its GSTIN is 27AAUCA8137F1ZA (Maharashtra).
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors including Hemangini Arun Chopade and Arun Dhondu Chopade.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nirankar Apartment Basement Plot No 47 Hill Road Ambernath, Maharashtra, India – 421501.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.08 Lakh. For the same year it recorded a net loss of ₹1.39 Cr and EBITDA of -₹65.77 Lakh. Revenue has grown at a compounded annual rate (CAGR) of 436% over three years.
As per MCA filings, the company has open charges of ₹4.5 Cr on record.
Company details
Recognitions & Rankings of Arlckon Biotech
Contact details
Arlckon Biotech Private Limited's registered office is in Ambernath, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNirankar Apartment Basement Plot No 47 Hill Road Ambernath, Maharashtra, India – 421501
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Arlckon Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Arlckon Biotech Private Limited
FY 2025 filings availableArlckon Biotech Private Limited reported revenue of ₹8.08 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 436% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹8.08 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹65.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.39 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arlckon Biotech Private Limited, buy the company report.
Board of directors of Arlckon Biotech Private Limited
Arlckon Biotech has 6 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemangini Arun Chopade Also directs: Alr Pharmatech Limited Liability Partnership | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Arun Dhondu Chopade Also directs: Alr Pharmatech Limited Liability Partnership | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Lalit Dhondu Chopade Also directs: Alr Pharmatech Limited Liability Partnership | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Manisha Ravindra Chopade Also directs: Alr Pharmatech Limited Liability Partnership | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Nayana Lalit Chopade Also directs: Alr Pharmatech Limited Liability Partnership | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Ravindra Dhondu Chopade Also directs: Alr Pharmatech Limited Liability Partnership | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Arlckon Biotech Private Limited is compared with the 10 companies closest to it by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neelagriva Bio Sciences Private Limited | ₹8.96 Lakh (FY 2025) | 7.0% | Srirangapatana, Karnataka, India | |||
| Tergene Biotech Limited | ₹8.94 Lakh (FY 2025) | -98.0% | Hyderabad, Telangana, India | |||
| Arsh Biotech Private Limited | ₹8.52 Lakh (FY 2024) | -73.0% | Delhi, India | |||
| Bharga Biotech and Re-Energy Solutions Private Limited | ₹8.5 Lakh (FY 2025) | Cherpulachery P O, Kerala, India | ||||
| G S Biotech Limited | ₹8.49 Lakh (FY 2018) | -96.0% | Adilabad, Telangana, India | |||
| Suu Saa Biotech Private Limited | ₹8.23 Lakh (FY 2025) | 6.0% | Delhi, India | |||
| Rakksha Biotech Private Limited | ₹8.21 Lakh (FY 2025) | 47.0% | Chennai, Tamil Nadu, India | |||
| Intergene Biosciences Private Limited | ₹8.21 Lakh (FY 2025) | 55.0% | Bangalore, Karnataka, India | |||
| D. E. Shaw Research India Technology Private Limited | ₹8.2 Lakh (FY 2019) | -26.0% | Hyderabad, Telangana, India | |||
| Arlckon Biotech Private Limitedthis company | ₹8.08 Lakh (FY 2025) | -₹1.39 Cr | Ambernath, Maharashtra, India | |||
| Chrogene Aarogyam Biotech Private Limited | ₹8.07 Lakh (FY 2024) | 572.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Arlckon Biotech Private Limited, buy the company report.
Auditor
Arlckon Biotech Private Limited is audited by Kiran Muthe & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kiran Muthe & Co | FY 2023 | 130229W |
Shareholding
The shareholding of Arlckon Biotech Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Arlckon Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jan 2024 | 100863770 | Others | ₹1.5 Cr | Open | |
| 20 Feb 2023 | 100684415 | Others | ₹3 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Arlckon Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arlckon Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Arlckon Biotech Private Limited has 1 active EPFO establishment as of Apr 02, 2024.
GST
Arlckon Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAUCA8137F1ZA | Maharashtra | Active | 23 Mar 2023 |
To see the full GST registrations and return filing status of Arlckon Biotech Private Limited, buy the company report.
Recent activity
Arlckon Biotech Private Limited has 6 board changes on record since 2021: 6 appointments. The latest: Arun Dhondu Chopade was appointed as Director on 12 Feb 2021.
Frequently asked questions
Arlckon Biotech is an active private limited company based in Ambernath, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 February 2021 (5+ years old) and is registered under CIN U24233MH2021PTC355143.
Arlckon Biotech has 6 current directors:
- Hemangini Arun Chopade - Director
- Arun Dhondu Chopade - Director
- Lalit Dhondu Chopade - Director
- Manisha Ravindra Chopade - Director
- Nayana Lalit Chopade - Director
- Ravindra Dhondu Chopade - Director
The latest financial statements of Arlckon Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Arlckon Biotech is 27AAUCA8137F1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Arlckon Biotech is U24233MH2021PTC355143. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arlckon Biotech was incorporated on 12 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Arlckon Biotech by revenue are Neelagriva Bio Sciences Private Limited, Tergene Biotech Limited, Arsh Biotech Private Limited, Bharga Biotech and Re-Energy Solutions Private Limited, G S Biotech Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Arun Dhondu Chopade was appointed as Director on 12 Feb 2021. Hemangini Arun Chopade was appointed as Director on 12 Feb 2021. Lalit Dhondu Chopade was appointed as Director on 12 Feb 2021. Arlckon Biotech has 6 board changes on record in total.
Yes, Arlckon Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Arlckon Biotech is at Nirankar Apartment Basement Plot No 47 Hill Road Ambernath, Maharashtra, India – 421501.
Arlckon Biotech operates in the pharma industry, in the drug formulation and development segment.

